Lifeboat Foundation

While supporting actors are often overlooked, without their contribution, a story’s main characters would lose context and resort to isolated monologues.

The same is true for neurons — the top-billing stars of cognition — when firing in the brain. Without cells called glia, which form the bulk of brain matter, neurons would stop communicating with each other, as seen in neurodegeneration. These supporting glial cells play countless critical roles in the nervous system such as maintaining the chemical environment of neurons and modulating their activity.

Although neurons still rightfully garner A-lister attention when it comes to developing brain therapies, Jeffrey Goldberg, MD, PhD, professor and chair of ophthalmology and the Blumenkranz Smead Professor, believes a young, underexplored class of therapies called gliotherapeutics, which target and harness glia, will ultimately provide important new directions for treatment.

Neuroresearchers at Macquarie University in Australia say they have developed a single-dose genetic medicine that has halted the progression of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) in mice. The team, which believes its approach may even offer the potential to reverse some of the effects of the fatal diseases, thinks it may also hold opportunities for treating more common forms of dementia, such as Alzheimer’s disease.

The new treatment, dubbed CTx1000, targets pathological build-ups of the protein TDP-43 in cells in the brain and spinal cord, which has been associated with ALS, FTD, and other forms of dementia. The scientists, led by Lars Ittner, PhD, hope to see CTx1000 begin human clinical trials in as little as two years. Their study “Targeting 14–3-3?-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice” appears in Neuron.

“Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are characterized by cytoplasmic deposition of the nuclear TAR-binding protein 43 (TDP-43). Although cytoplasmic re-localization of TDP-43 is a key event in the pathogenesis of ALS/FTD, the underlying mechanisms remain unknown. Here, we identified a non-canonical interaction between 14–3-3θ and TDP-43, which regulates nuclear-cytoplasmic shuttling,” wrote the investigators.

Implants and other technologies that decode neural activity can restore people’s abilities to move and speak — and help researchers to understand how the brain works.

The idea that the electrical activity of the human brain could be recorded first gained support 100 years ago.

Eye contact and body language are critical in social interaction, but exactly how the brain uses this information in order to inform behavior in real time is not well understood.

By combining behavioral and wireless eye tracking and neural monitoring, a team of Rice University scientists and collaborators studied how pairs of freely moving macaques interacting in a naturalistic setting use visual cues to guide complex, goal-oriented cooperative behavior. The study published in Nature offers first evidence that the part of the brain that processes visual information ⎯ the visual cortex ⎯ plays an active role in social behavior by providing an executive area ⎯ the prefrontal cortex ⎯ with the signals necessary to generate the decision to cooperate.

We are the first to use telemetric devices to record neural activity from multiple cortical populations in the visual and prefrontal cortex while animals explore their environment and interact with one another. When primates, including humans, interact, we make eye contact and use body language to indicate to conspecifics what we want to do.

Summary: Researchers unlocked how the brain processes melodies, creating a detailed map of auditory cortex activity. Their study reveals that the brain engages in dual tasks when hearing music: tracking pitch with neurons used for speech and predicting future notes with music-specific neurons.

This breakthrough clarifies the longstanding mystery of melody perception, demonstrating that some neural processes for music and speech are shared, while others are uniquely musical. The discovery enhances our understanding of the brain’s complex response to music and opens avenues for exploring music’s emotional and therapeutic impacts.

A new study by researchers at UC San Francisco provides new insight into how the brain processes musical melodies. Through precise mapping of the cerebral cortex, the study uncovered that our brains process music by not only discerning pitch and the direction of pitch changes but also by predicting the sequence of upcoming notes, each task managed by distinct sets of neurons. The findings have been published in Science Advances.

Previous research had established that our brains possess specialized mechanisms for processing speech sounds, particularly in recognizing pitch changes that convey meaning and emotion. The researchers hypothesized that a similar, perhaps specialized, set of neurons might exist for music, dedicated to predicting the sequence of notes in a melody, akin to how certain neurons predict speech sounds.

“Music is both uniquely human and universally human. Studying the neuroscience of music can therefore reveal something fundamental about what it means to be human,” said lead author Narayan Sankaran, a postdoctoral fellow in the Kavli Center for Ethics, Science, and the Public at UC Berkeley, who conducted the study while a researcher in the lab of UCSF’s Edward Chang.

Listening to electronic music makes neurons in our brain fire in time with the beat, which appears to alter our reaction time and sense of unity.

By Conor Feehly

Scientists are investigating whether an oral drug sprinkled with gold nanoparticles could one day treat neurodegenerative diseases like Parkinson’s and multiple sclerosis.

The experimental medicine, called CNM-Au8, has now shown success in boosting the brain’s metabolism in phase II clinical trials.

Research on the safety and efficacy of the daily drug is still ongoing, but the initial results have researchers hopeful. The medicine contains suspended nanoparticles of gold that can apparently pass the blood-brain barrier and improve energy supply to neurons, preventing their decline.

Elon Musk shared an update on Neuralink’s first human patient and their experience with the N1 chip.

The first human Neuralink patient seems to have made a full recovery with no ill effects and is able to control the mouse around the screen just by thinking, said Elon Musk during an apparent on X Spaces.

Musk added that Neuralink continuously observes the patient’s ability to use the N1 brain implant. The patient is currently tasked to click on the mouse button as often as possible.